The Leadership Team at Moleculin drives the strategic direction and operational effectiveness of the company, focusing on the advancement of innovative oncology drug candidates. Comprised of executive leaders in scientific, financial, and medical domains, the team collaborates to ensure successful clinical development, regulatory compliance, and market readiness, ultimately aiming to improve treatment options for patients with highly resistant tumors.
View all